HQL vs VXUS
HQL vs VXUS
Do a full portfolio x-ray
$25 once. No subscription. Download sample.
HQL vs VXUS
abrdn Life Sciences Investors vs Vanguard Total International Stock ETF
Do a full portfolio x-ray
$25 once. No subscription. Download sample.
Quick Verdict
VXUS offers more diversification with 8,747 holdings.
Lower Fees: TiedHigher Returns: TiedMore Diversified: VXUS
Side-by-Side Comparison
| Metric | HQL | VXUS | Winner |
|---|---|---|---|
| Expense Ratio | - | 0.05% | |
| AUM | - | $158.1B | |
| Dividend Yield | - | 2.59% | |
| Holdings | 0 | 8,747 | |
| YTD Return | - | +15.22% | |
| 1Y Return | - | +26.86% | |
| 3Y Return (annualized) | - | +20.34% | |
| 5Y Return (annualized) | - | +9.38% | |
| Volatility (annualized) | - | 15.1% | |
| Max Drawdown | - | -39.9% | |
| Fund Family | abrdn Life Sciences Investors | Vanguard (US) | |
| Category | - | Equity | |
| Inception | - | Jan 26, 2011 |
HQL vs VXUS Performance
abrdn Life Sciences Investors (HQL) is a ETF from abrdn Life Sciences Investors and Vanguard Total International Stock ETF (VXUS) is a ETF from Vanguard (US).
Frequently Asked Questions
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.
Do a full portfolio x-ray
$25 once. No subscription. Download sample.